Revenue during the quarter grew 3.98 percent to $38,169.26 million from $36,709.05 million in the previous year period. Gross margin for the quarter expanded 9 basis points over the previous year period to 2.72 percent. Operating margin for the quarter period stood at positive 1.05 percent as compared to a negative 0.49 percent for the previous year period.

Operating income for the quarter was $399.99 million, compared with an operating loss of $178.14 million in the previous year period.

However, the adjusted operating income for the quarter stood at $486.20 million compared to $476.82 million in the prior year period. At the same time, adjusted operating margin contracted 3 basis points in the quarter to 1.27 percent from 1.30 percent in the last year period.

"I am very pleased with the strong performance we delivered in the December quarter and the improved outlook and financial guidance we are providing for fiscal year 2017," said Steven H. Collis, chairman, president and chief executive officer of AmerisourceBergen. "AmerisourceBergen continues to execute and succeed within a challenging healthcare landscape by offering our customers the most innovative and business-critical solutions needed to drive their growth while carefully controlling operating expenses. The customer response to our services and enhanced offerings has been extremely positive and they are helping AmerisourceBergen and our customers achieve our respective business goals."

For fiscal year 2017, AmerisourceBergen Corporation forecasts revenue to grow in the range of 6.50 percent to 8 percent. It expects diluted earnings per share to be in the range of $5.72 to $5.92 on adjusted basis. Adjusted operating income in the range of flat to up 4 percent for the same period.

The company has spent $156.86 million cash to meet investing activities during the quarter as against cash outgo of $2,772.49 million in the last year period.

The company has spent $363.49 million cash to carry out financing activities during the quarter as against cash inflow of $831.52 million in the last year period.

Cash and cash equivalents stood at $1,791.13 million as on Dec. 31, 2016, up 83.13 percent or $813.04 million from $978.09 million on Dec. 31, 2015.

Working capital remains negative
Working capital of AmerisourceBergen Corporation was negative $2,464 million on Dec. 31, 2016 compared with negative $3,662.67 million on Dec. 31, 2015. Current ratio was at 0.90 as on Dec. 31, 2016, up from 0.85 on Dec. 31, 2015.

Cash conversion cycle (CCC) has increased to 20 days for the quarter from 9 days for the last year period. Days sales outstanding were almost stable at 22 days for the quarter, when compared with the last year period.

Days inventory outstanding has decreased to 14 days for the quarter compared with 27 days for the previous year period. At the same time, days payable outstanding was almost stable at 56 days for the quarter, when compared with the previous year period.